Integrative Chiropractic Care for Pain Relief From OUD

Find out how integrative chiropractic care for OUD can enhance your quality of life through tailored treatments.

Abstract: Navigating the Complexities of Opioid Use Disorder

Opioid use disorder (OUD) is a chronic neurobiological condition. Medications for opioid use disorder (MOUD) remain the treatment with the strongest evidence for reducing overdose death. In integrative practice, a large share of opioid exposure starts in the musculoskeletal system: a disc injury, facet irritation, whiplash, sciatica, or months of guarded motion that opioids were asked to cover. The drug then adds its own injuries, including opioid-induced hyperalgesia, withdrawal myalgias, deconditioning, and, in people who inject, bone and soft-tissue infection.

This educational post explains how integrative chiropractic care acts on those tissues. Spinal and extremity joint care, spinal decompression when indicated, soft-tissue treatment, posture and kinetic-chain retraining, and autonomic downshifting reduce nociceptive input and the sympathetic load that amplifies pain and craving. These services do not replace methadone, buprenorphine, or naltrexone. They reduce the biomechanical reasons patients reach for opioids and make it easier to stay in MOUD and rehabilitation.

Clinical observations from my practice, shared at chiromed.com and on LinkedIn, are paired with current public-health figures and peer-reviewed evidence. Medical safety, diagnostics, and medication management are overseen by our Medical Director, Dr. Maria Guadalupe Cardenas, MD, board-certified in internal medicine (NPI 1164426749; Texas MD License J2933).

Where Opioid Use Starts in the Body

Many patients I see did not set out to develop OUD. They came for neck pain after a collision, lumbar pain after a lift, mid-back fatigue that showed up before the low back failed, or sciatica that began as a guarded bend. Opioids were started for a real nociceptive problem. When the segment, disc, or nerve was never restored, the prescription became the coping strategy.

That pattern is visible on examination. Restricted joints create a local inflammatory microenvironment and paraspinal hypertonicity. The thorax often tires first: rib-cage stiffness, shallow breathing, and a mid-back that fatigues before the lumbar spine declares itself. Hips stop hinging. The lumbar spine flexes instead. Adjacent regions then hurt because the kinetic chain is compensating. Sedentary recovery, poor sleep, and prolonged sitting add ergonomic load on top of the original injury. Clinically, the combined profile is familiar: chronic neck or low back pain, high stress, broken sleep, and escalating reliance on opioids or sedatives (Jimenez, n.d.-a).

Pain of this kind is not only local. Central sensitization, the amplification of pain signals in the spinal cord and brain, tracks with pain as a reason for starting opioids, continuing them, escalating the dose, delaying treatment, and relapsing (Hall et al., 2022). Chronic opioid exposure can itself raise pain sensitivity. Opioid-induced hyperalgesia is the clinical face of that change: pain spreads, restlessness appears, and dose increases stop helping.

Public-health numbers have improved, but they remain severe. Provisional data from the CDC National Center for Health Statistics estimate 69,973 drug overdose deaths in the United States in 2025, down almost 14% from 81,313 in 2024. Deaths involving opioids fell from an estimated 55,296 in 2024 to 44,564 in 2025 (Centers for Disease Control and Prevention [CDC], 2026). These counts are provisional. In the 2024 National Survey on Drug Use and Health, 4.8 million people aged 12 or older had a past-year opioid use disorder, and only 17% (about 818,000 people) received MOUD (Substance Abuse and Mental Health Services Administration [SAMHSA], 2025). Most people who meet criteria are untreated. An integrative clinic that can treat the spine and coordinate medication in the same plan can help close that gap.

What OUD and Opioids Do to the Musculoskeletal System

OUD remakes how the musculoskeletal system moves, hurts, and heals. That is why chiropractic care belongs in the plan.

Joint restriction and subluxation complexes. Pain teaches the nervous system to lock segments. Cervical facets stop gliding after whiplash. Lumbar segments stop extending. The thorax stiffens. Lost joint play means lost mechanoreceptor input and more nociceptor input. Over months, capsule thickening, muscle inhibition, and poor proprioception turn an acute injury into a chronic generator. Viscerosomatic stress can travel with this picture: a guarded thorax changes breathing, and a guarded lumbar spine changes how the patient loads the pelvis and gut wall during every lift.

Peripheral and central sensitization. Injured discs, facet capsules, and paraspinal muscles release substance P, calcitonin gene-related peptide, tumor necrosis factor-alpha, interleukin-1 beta, and prostaglandin E2. Those mediators lower the firing threshold of A-delta and C fibers. Repeated C-fiber input opens NMDA channels in the dorsal horn, so ordinary touch and joint motion are read as pain. Opioid-induced hyperalgesia pushes the same system further (Hall et al., 2022).

Withdrawal myalgias and autonomic surge. Opioid withdrawal is a musculoskeletal event. Bone and joint aches, restless legs, sweating, tremor, and piloerection are scored on the Clinical Opiate Withdrawal Scale because they are reliable (Wesson & Ling, 2003). Sympathetic overdrive tightens paraspinal, scalene, and jaw muscles, wrecks sleep, and makes craving feel physical. Patients often say they no longer use to feel high. They use so they do not feel sick.

Deconditioning and mid-back failure. Sedation, poor sleep, and low protein intake strip the muscles that should brace the spine. A weak deep core and inhibited gluteals leave the disc and facets taking load the hips should have shared. The mid-back tires early because rib-cage motion and thoracic endurance are lost. Falls from sedation add sprains and new prescriptions.

Injection-related bone and soft-tissue injury. People who inject are at risk for abscess, cellulitis, septic arthritis, osteomyelitis, and endocarditis, often from Staphylococcus aureus, including MRSA. These are medical emergencies until infection is controlled. Xylazine, an alpha-2 adrenergic adulterant, adds ischemic necrosis that may appear away from the injection site and limits weight-bearing (Gupta et al., 2023). Naloxone does not reverse xylazine. Airway support still comes first.

Comorbid pain syndromes. Sciatica, cervical radiculopathy, thoracic stiffness, fibromyalgia-like nociplastic pain, headache, and widespread hyperalgesia commonly travel with OUD. Depression, anxiety, trauma, and post-traumatic stress travel with them. Untreated, each one is a relapse trigger. Treated, each one becomes a milestone the patient can feel in sleep or at work.

How Chiropractic Care Changes the Musculoskeletal System

In this model, chiropractic care is a sequence aimed at the tissues that keep sending danger signals. It is not a standalone treatment for OUD.

Joint motion. High-velocity, low-amplitude adjustments, when screening is clear, stimulate mechanoreceptors in the capsule and paraspinal muscles. Large-diameter afferents enter the dorsal horn and activate inhibitory interneurons that reduce C-fiber traffic (Pickar, 2002). Restored segmental motion unloads a swollen facet, improves disc nutrition through movement, and returns position sense. That input can also engage descending inhibition from the periaqueductal gray. For hyperalgesic or deconditioned patients, I start with low-force mobilization and instrument-assisted work. Fear-avoidance falls when the first sessions do not spike pain. I add HVLA only after excluding osteoporosis, coagulopathy, fracture, infection, and malignancy.

Disc and nerve load. When herniation or radiculopathy drives symptoms, flexion-distraction or mechanical spinal decompression reduces mechanical tension on the disc and nerve root, paired with stabilization rather than used alone. Neurodynamic glides follow once irritability drops. The goal is less peripheral sensitization, not a promise that decompression replaces medication.

Muscle and fascia. Soft-tissue work reduces trigger points and restores fascial glide. Myofascial hypertonicity is both a pain source and a sympathetic marker. Releasing it lowers the local chemical irritation that keeps dorsal-horn wind-up going.

Kinetic chain and posture. Care runs from the cervical and thoracic spine to the lumbopelvic segments. Hip-hinge mechanics, core endurance, and gluteal activation put compression back where it belongs. Mid-back mobility and rib-cage motion are treated early, because a stiff thorax keeps sympathetic tone high and sleep shallow. Short movement doses through the day sustain the change better than one hard session a week.

Autonomic tone. Withdrawal and chronic pain both raise sympathetic drive. Gentle manipulation, paced breathing, and progressive exercise lower that drive and support parasympathetic recovery. In practice, sleep and mood often improve once this load drops. I do not claim the adjustment treats insomnia or depression. I claim a stiff, sympathetic spine is one reason these patients cannot downshift at night.

The evidence that this sequence lowers opioid exposure should be stated at its actual strength. Among New Hampshire adults with office visits for noncancer low back pain, receipt of chiropractic services was associated with a 55% lower likelihood of filling an opioid prescription (odds ratio 0.45; 95% CI 0.40-0.47) (Whedon et al., 2018). In active-duty service members, adding chiropractic care to usual medical care produced moderate short-term gains in pain and disability and lower self-reported pain-medication use at six weeks (odds ratio 0.73; 95% CI 0.54-0.97) (Goertz et al., 2018). A 2025 systematic review and meta-analysis found very low-certainty evidence that chiropractic care may reduce the odds of receiving prescription opioids for noncancer spine pain by about 64% (OR 0.36; 95% CI 0.25-0.52), with a larger association when care started within 30 days (Emary et al., 2025). Early musculoskeletal care appears to matter more than late care. These studies are mostly observational. They support less opioid exposure for spine pain. They do not show that adjustment treats OUD by itself.

Where Chiropractic Care Fits With MOUD

MOUD is the mortality intervention. Methadone and buprenorphine are associated with substantially lower mortality during treatment than no medication or treatment stopped (Sordo et al., 2017). After a nonfatal overdose, methadone and buprenorphine are associated with lower all-cause and opioid-related mortality (Larochelle et al., 2018). Buprenorphine is a partial mu-opioid agonist with a ceiling on respiratory depression and a receptor affinity high enough to blunt many full agonists (SAMHSA, 2021). Office-based prescribing no longer requires an X-waiver (SAMHSA, 2023). Naltrexone blocks receptors without activating them, but it requires a full detoxification and carries a high overdose risk if it is stopped and use resumes (Lee et al., 2018).

Chiropractic care does not compete with that pharmacology. It handles the reason many patients say the medication is “not enough”: the neck, the mid-back, the leg, the inability to work. In our clinic, the sequence is deliberate.

1. Safety first: naloxone in hand, fentanyl and xylazine risk discussed, infectious-disease screening, and no punitive response to a positive urine drug test.
2. MOUD selection and induction under Dr. Cardenas’s medical direction. For fentanyl-exposed patients, micro-induction is safer than a standard start, because fentanyl stored in fat raises the risk of precipitated withdrawal (Ahmed et al., 2021).
3. Hands-on care stays low-force during induction so we do not spike autonomic arousal while withdrawal is still active.
4. As cravings settle, we add segmental care, decompression if a disc is the driver, kinetic-chain retraining, and graded strength.
5. We do not add full-agonist analgesics on top of buprenorphine for mechanical pain that can be rehabilitated.

Withholding MOUD because a patient is still using is not harm reduction. Withholding rehabilitation because a patient is on buprenorphine is also a mistake.

Clinical Observations From Practice

These observations come from integrative care at ChiroMed and Injury Medical Clinic PA and are discussed at chiromed.com and on my LinkedIn profile. They are practice patterns, not trial results.

When musculoskeletal care reduces nociceptive input and improves function, patients report fewer cravings tied to pain spikes. Patients stabilized on MOUD often gain pain reduction and function faster when non-opioid musculoskeletal care is integrated early, not after months of medication alone. Autonomic balancing through breathwork, gentle manipulation, and progressive exercise improves sleep and mood, which are the pillars that keep recovery intact between visits. A nonpunitive team makes lapses easier to disclose so that the plan can change before a flare becomes a return to fentanyl.

The body patterns repeat. Whiplash leaves cervical hypomobility, headache, and upper-limb paresthesia; restoring cervical and thoracic motion, then retraining deep neck flexors, reduces the flare patients had been covering with short-acting opioids. Lumbar disc-related radicular pain responds when decompression or mobilization is paired with hip-hinge and core work, not when either is used alone. Mid-back stiffness is an early marker: if the thorax cannot move, sleep stays shallow and next-day pain rises. Hyperalgesic patients do better when the first sessions are low-force. HVLA is a later tool, not an induction-week tool.

A recurring case shape is the patient on buprenorphine with unsettled low back or neck pain. Medication continuity comes first. Mechanical care, graded exercise, and pain reframing come with it. Full-agonist analgesics are not added to chase a mechanical flare. The functional goal, a shift tolerated or a night slept, predicts retention better than a pain score of zero.

Comorbidities We Treat in the Same Plan

Musculoskeletal comorbidities of OUD are not side issues.

• Withdrawal myalgia eases when the dose is adequate and when paraspinal guarding is treated. Chiropractic care does not replace a correct buprenorphine or methadone dose.
• Opioid-induced hyperalgesia is a signal to stop escalating full agonists and to rebuild descending inhibition with movement, education, and MOUD.
• Treat deconditioning with protein-adequate meals, daily walking, and progressive loading once infection and cardiac status are clear.
• Manage post-infection stiffness after treated septic arthritis with rehabilitation, coordinated with the physician who cleared the patient.
• Xylazine wounds need wound care first. We protect load-bearing around dressings. We do not mobilize through active necrosis.
• Co-use of benzodiazepines and alcohol raises overdose risk. We do not add sedating techniques that leave a patient orthostatic.
• Trauma, depression, and post-traumatic stress are named and referred. Manual care can lower bodily threat. It does not replace trauma-focused therapy.
• Nociplastic pain and fibromyalgia-like spread are approached with graded exposure and pain neuroscience education, not with more opioids.
• Pregnancy changes tissue laxity and balance. Methadone and buprenorphine remain the pharmacologic standards (American College of Obstetricians and Gynecologists, 2017). Manual care stays gentle.

Harm reduction sits under all of this. Naloxone for every patient at risk, fentanyl test-strip education, coordination with syringe service programs, and the rule that a return to use is data, not discharge (National Harm Reduction Coalition, n.d.). Motivational interviewing, using open questions, affirmations, reflections, and summaries, is how we set the next mobility goal without a lecture (Miller & Rollnick, 2013). Relapse is a stage in a chronic illness, not a failure of character (Prochaska & DiClemente, 1983).

The Clinic Model

Dr. Cardenas provides diagnostic leadership, internal-medicine management, MOUD selection, EKG review before methadone, liver monitoring where injectables or naltrexone require it, and infectious-disease screening. I provide the neuromusculoskeletal examination, chiropractic care, spinal decompression when indicated, functional-medicine support, and rehabilitation direction, and I prescribe buprenorphine and naltrexone under that medical collaboration. Personal-injury rehabilitation sits in the same pathway, because the collision or work injury that started the opioid prescription is often still the pain generator.

What This Does Not Claim

Chiropractic care does not reverse an overdose, occupy mu-opioid receptors, or substitute for methadone, buprenorphine, or naltrexone. It does not treat endocarditis, necrotizing infection, or pregnancy-related OUD without medical care. Observational associations between chiropractic visits and fewer opioid fills can be affected by who seeks that care. The honest claim is narrower and still clinically important: restoring joint motion, disc and nerve mechanics, muscle capacity, and autonomic balance removes musculoskeletal drivers of opioid use, lowers craving tied to pain flares, and makes MOUD and counseling easier to stay in. That is how chiropractic care reduces OUD risk in an integrative clinic. It treats the body that has been using opioids to solve a mechanical problem.

References

Ahmed, S., Bhivandkar, S., Lonergan, B. B., & Suzuki, J. (2021). Microinduction of buprenorphine/naloxone: A review of the literature. The American Journal on Addictions, 30(4), 305-315.

American College of Obstetricians and Gynecologists. (2017). Opioid use and opioid use disorder in pregnancy (Committee Opinion No. 711). Obstetrics & Gynecology, 130(2), e81-e94.

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.

Centers for Disease Control and Prevention. (2026, May 13). U.S. overdose deaths decrease for third consecutive year in 2025. National Center for Health Statistics.

Emary, P. C., Corcoran, K. L., Coleman, B. C., Brown, A. L., Ciraco, C., DiDonato, J., Wang, L., Couban, R. J., Sud, A., & Busse, J. W. (2025). Impact of chiropractic care on opioid use for noncancer spine pain: Systematic review and meta-analysis. PAIN Reports, 11(1), e1374.

Goertz, C. M., Long, C. R., Vining, R. D., Pohlman, K. A., Walter, J., & Colter, I. (2018). Effect of usual medical care plus chiropractic care vs usual medical care alone on pain and disability among US service members with low back pain: A comparative effectiveness clinical trial. JAMA Network Open, 1(1), e180105.

Gupta, R., Holtgrave, D. R., & Ashburn, M. A. (2023). Xylazine: Medical and public health imperatives. The New England Journal of Medicine, 388(24), 2209-2212.

Hall, O. T., Teater, J., Rood, K. M., Phan, K. L., & Clauw, D. J. (2022). Central sensitization in opioid use disorder: A novel application of the American College of Rheumatology Fibromyalgia Survey Criteria. PAIN Reports, 7(4), e1016.

Jimenez, A. (n.d.-a). Clinical observations on integrative chiropractic care, musculoskeletal pain, and recovery. ChiroMed.

Jimenez, A. (n.d.-b). Professional profile and clinical updates. LinkedIn.

Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine, 169(3), 137-145.

Lee, J. D., Nunes, E. V., Jr., Novo, P., Bach, V., Bailey, G. L., Bhatt, S., & Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: B OT): A multicentre, open-label, randomized controlled trial. The Lancet, 391(10118), 309-318.

Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.

National Harm Reduction Coalition. (n.d.). Overdose prevention. National Harm Reduction Coalition.

Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. The Spine Journal, 2(5), 357-371.

Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390-395.

Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ, 357, j1550.

Substance Abuse and Mental Health Services Administration. (2021). Medications for opioid use disorder (Treatment Improvement Protocol 63, Publication No. PEP21-02-01-002). U.S. Department of Health and Human Services.

Substance Abuse and Mental Health Services Administration. (2023). Waiver elimination (MAT Act). U.S. Department of Health and Human Services.

Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007). Center for Behavioral Health Statistics and Quality.

Wesson, D. R., & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs, 35(2), 253-259.

Whedon, J. M., Toler, A. W. J., Goehl, J. M., & Kazal, L. A. (2018). Association between utilization of chiropractic services for treatment of low-back pain and use of prescription opioids. Journal of Alternative and Complementary Medicine, 24(6), 552-556.

SEO Tags

opioid use disorder, OUD, chiropractic care, musculoskeletal pain, spinal decompression, central sensitization, opioid-induced hyperalgesia, buprenorphine, methadone, naltrexone, MOUD, harm reduction, naloxone, low back pain, neck pain, sciatica, thoracic stiffness, kinetic chain, autonomic regulation, withdrawal myalgia, integrative rehabilitation, ChiroMed, Injury Medical Clinic PA, El Paso Texas, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, non-opioid pain management, fentanyl, xylazine, pain neuroscience education, viscerosomatic stress, subluxation complex